LGND
Ligand Pharmaceuticals Incorporated
$170.77
+$4.26(+2.56%)
72
Overall
--
Value
72
Tech
--
Quality
Market Cap
$3.26B
Volume
256.77K
52W Range
$93.58 - $170.78
Target Price
$184.29
Key Metrics Overview
| Market Cap | $3.26B | P/E Ratio | 550.87 |
| 52W High | $170.78 | 52W Low | $93.58 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -28.1% | 52W Position | 100.0% |
| Overall Score | 72 | Value Score | -- |
| Quality Score | -- | Technical Score | 72 |
Growth Analysis
| EPS Current Est | $0.31 | EPS Next Est | $4.66 |
| EPS Growth Est | +1403.2% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $170.77 | +2.6% | 256.77K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW